Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality.

[1]  Mark D. Huffman,et al.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[2]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[4]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[5]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[6]  Klaus Mann,et al.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.

[7]  P. Greenland,et al.  Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.

[8]  R. Detrano,et al.  Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis. , 2010, Atherosclerosis.

[9]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[10]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[11]  M. Budoff,et al.  Screening for heart disease: C-reactive protein versus coronary artery calcium , 2010, Expert review of cardiovascular therapy.

[12]  M. Pencina,et al.  Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.

[13]  L. Smeeth,et al.  Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. , 2009, International journal of epidemiology.

[14]  Mary Cushman,et al.  Practice Guidelines : Emerging Biomarkers for Primary Prevention of Cardiovascular Disease , 2009 .

[15]  R. Kronmal,et al.  Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). , 2009, Journal of the American College of Cardiology.

[16]  M. Stuart,et al.  Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein (CRP) , 2009 .

[17]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[18]  J. J. Rivera,et al.  Markers of inflammation and coronary artery calcification: a systematic review. , 2008, Atherosclerosis.

[19]  Leslee J Shaw,et al.  Coronary artery calcium to predict all-cause mortality in elderly men and women. , 2008, Journal of the American College of Cardiology.

[20]  D. Grönemeyer,et al.  Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation. , 2008, Atherosclerosis.

[21]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[22]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[23]  R. Detrano,et al.  Abstract 3654: Inflammation Factors, Coronary Calcium and Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2007 .

[24]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[25]  D. Berman,et al.  Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. , 2007, Journal of the American College of Cardiology.

[26]  R. Kronmal,et al.  Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. , 2007, Atherosclerosis.

[27]  T. Hansen,et al.  N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. , 2007, European heart journal.

[28]  P. Ridker.  C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. , 2007, Journal of the American College of Cardiology.

[29]  Daniel S Berman,et al.  Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. , 2007, Journal of the American College of Cardiology.

[30]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[31]  Paul M. Ridker,et al.  Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women , 2007 .

[32]  Nancy R Cook,et al.  The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women , 2006, Annals of Internal Medicine.

[33]  D. Grönemeyer,et al.  Population-based assessment of subclinical coronary atherosclerosis using electron-beam computed tomography. , 2006, Atherosclerosis.

[34]  Michael McNitt-Gray,et al.  Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility--MESA study. , 2005, Radiology.

[35]  Y. Arad,et al.  Objectives Background Methods Results Conclusions , 2022 .

[36]  Daniel S Berman,et al.  Prognostic value of coronary artery calcium screening in subjects with and without diabetes. , 2004, Journal of the American College of Cardiology.

[37]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[38]  C. Meisinger,et al.  C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score: Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany , 2004, Circulation.

[39]  B. Thompson,et al.  Coronary artery calcium quantification at multi-detector row helical CT versus electron-beam CT. , 2004, Radiology.

[40]  D. Berman,et al.  Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. , 2003, Radiology.

[41]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[42]  Robert Detrano,et al.  Combined Use of Computed Tomography Coronary Calcium Scores and C-Reactive Protein Levels in Predicting Cardiovascular Events in Nondiabetic Individuals , 2002, Circulation.

[43]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[44]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[45]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[46]  I. Ringqvist,et al.  Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). , 1983, The Journal of clinical investigation.

[47]  David A. Schoenfeld,et al.  Partial residuals for the proportional hazards regression model , 1982 .